Labcorp poster describes a direct format for neutralizing anti-drug antibody assays
Company / institutional announcement · Labcorp
Source published: · Event / reporting date: 2026-10-30
Site published: 2026-11-06 · Updated: 2026-11-06
This source is linked automatically. Choose a question to get started.
What changed
Labcorp posted a CBF 2026 conference-poster summary describing a direct assay format for neutralizing anti-drug antibodies. The approach is intended to address limitations of competitive assays when drug–target affinity is weak or signals are unstable. The public summary presents the assay concept, rather than quantitative validation results or a peer-reviewed clinical study.
Why it may matter
Analysis: A direct format may offer an alternative assay-development route when competitive binding limits performance, subject to fit-for-purpose validation.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections